LISATA THERAPEUTICS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Assets, Goodwill and Intangible Assets of $621.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $621.00K.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $765.00K.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $889.00K.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $944.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets | Deferred Tax Assets, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2025-12-31 | $621.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $765.00K 10-K · filed 2026-03-12 | |
| 2023-12-31 | $889.00K 10-K · filed 2025-02-27 | |
| 2022-12-31 | $944.00K 10-K · filed 2024-02-29 | |
| 2021-12-31 | $97.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $131.00K 10-K · filed 2022-03-22 | |
| 2019-12-31 | $141.00K 10-K · filed 2021-02-25 | |
| 2018-12-31 | $199.00K 10-K · filed 2020-03-05 | |
| 2017-12-31 | $270.00K 10-K · filed 2019-03-14 | |
| 2016-12-31 | $429.00K 10-K · filed 2018-03-22 | $897.80K 10-K · filed 2017-03-17 |
| 2015-12-31 | $899.70K 10-K · filed 2017-03-17 | |
| 2014-12-31 | $715.10K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $287.30K 10-K · filed 2016-03-15 | $704.60K 10-K · filed 2014-03-13 |
| 2012-12-31 | $287.30K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |